Literature DB >> 28142387

Effects of Sustained Competitive Employment on Psychiatric Hospitalizations and Quality of Life.

Dorothea Jäckel1, Zeno Kupper1, Sibylle Glauser1, Kim T Mueser1, Holger Hoffmann1.   

Abstract

OBJECTIVE: There is extensive evidence for the effectiveness of supported employment among people with severe mental illness. However, less research has been conducted to evaluate the effects of sustained competitive employment on nonvocational outcomes. The aim of this study was to evaluate the effects of sustained competitive work on quality of life and psychiatric hospitalizations.
METHODS: As part of a randomized controlled trial, a mediation analysis was used to compare the direct and indirect effects of supported employment versus a traditional vocational program on sustained competitive employment, days of psychiatric hospitalization, and quality of life among 85 participants over five years.
RESULTS: The five-year follow-up indicated that the effects of supported employment on reduced days of hospitalization and increased quality of life were fully mediated by the program's effects on increasing sustained competitive employment.
CONCLUSIONS: The rehabilitative and therapeutic dimensions of functional health conditions are interrelated in the long term. The achievement of sustained competitive employment may be a key factor in improving social and psychiatric outcomes for people with severe and persistent mental disorders.

Entities:  

Keywords:  Hospitalization; Outcome studies; Quality of life; Supported employment; Vocational rehabilitation

Mesh:

Year:  2017        PMID: 28142387     DOI: 10.1176/appi.ps.201600083

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  7 in total

1.  Risperidone versus olanzapine among patients with schizophrenia participating in supported employment: Eighteen-month outcomes.

Authors:  Douglas L Noordsy; Shirley M Glynn; Catherine A Sugar; Christopher D O'Keefe; Stephen R Marder
Journal:  J Psychiatr Res       Date:  2017-09-08       Impact factor: 4.791

2.  Effect of Evidence-Based Supported Employment vs Transitional Work on Achieving Steady Work Among Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial.

Authors:  Lori L Davis; Tassos C Kyriakides; Alina M Suris; Lisa A Ottomanelli; Lisa Mueller; Pamela E Parker; Sandra G Resnick; Richard Toscano; Alexandra A Scrymgeour; Robert E Drake
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

3.  Who benefits from individual placement and support? A meta-analysis.

Authors:  Lars de Winter; Chrisje Couwenbergh; Jaap van Weeghel; Sarita Sanches; Harry Michon; Gary R Bond
Journal:  Epidemiol Psychiatr Sci       Date:  2022-07-11       Impact factor: 7.818

4.  Supported employment: Meta-analysis and review of randomized controlled trials of individual placement and support.

Authors:  Donald E Frederick; Tyler J VanderWeele
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

5.  Return-to-work-experts for inpatient treatment of patients with mental illnesses- a proof-of-concept-study (RETURN): the study protocol.

Authors:  Lina Riedl; Daniela Blank; Monika Kohl; Anne Lang; Victoria Kehl; Peter Brieger; Johannes Hamann
Journal:  BMC Psychiatry       Date:  2020-04-19       Impact factor: 3.630

6.  Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers.

Authors:  Minna Holm; Heidi Taipale; Antti Tanskanen; Jari Tiihonen; Ellenor Mitterdorfer-Rutz
Journal:  Acta Psychiatr Scand       Date:  2020-11-24       Impact factor: 6.392

7.  Predictors of competitive employment in individuals with severe mental illness: results from an observational, cross-sectional study in Germany.

Authors:  Johanna Breilmann; Steffi G Riedel-Heller; Uta Gühne; Alexander Pabst; Markus Kösters; Alkomiet Hasan; Peter Falkai; Reinhold Kilian; Andreas Allgöwer; Klemens Ajayi; Jessica Baumgärtner; Peter Brieger; Karel Frasch; Stephan Heres; Markus Jäger; Andreas Küthmann; Albert Putzhammer; Bertram Schneeweiß; Michael Schwarz; Thomas Becker
Journal:  J Occup Med Toxicol       Date:  2022-01-18       Impact factor: 2.646

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.